Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (AFLURIA) | SEQIRUS, INC. | 1 | AX5590A | IM / LA |
Reported Symptoms: 10013573:DIZZINESS; 10037087:PRURITUS; 10037844:RASH; Narrative: Patient presented to ED with chief complaint of pruritic rash to bilateral upper extremities and dizziness approximately 30 minutes after receiving Influenza, Trivalent, Preservative Free (Afluria-Syringe), administered intramuscular to left deltoid. He was elevated by the ED attending, no airway involvement or signs of anaphylaxis were noted, and symptoms resolved after administration of diphenhydramine, methylprednisolone, famotidine, and IV fluids. Vitals were stable during ED course. Patient was discharged home. Reaction was considered mild by ED attending. Patient reports tolerating flu vaccines in the past with no noted reactions. Other Relevant HX: Patient present to ED 9/24/25 with chief complain of pruritic rash to bilateral upper extremities and dizziness approximately 30 minutes after receiving Influenza, Trivalent, Preservative Free (Afluria-Syringe), administered intramuscular to left deltoid. He was evaluated by the ED attending, no airway involvement or signs of anaphylaxis were noted, and symptoms resolved after administration of diphenhydramine, methylprednisolone, famotidine, and IV fluids. Vitals were stable during ED course. Patient was discharged home. Reaction was considered mild by ED attending. Patient reports tolerating flu vaccines in the past with no noted reactions. Other: